Vienna, Austria, (September 7th 2011) -- F-Star GmbH today announced that a research, license and commercialisation agreement was signed with Merck Serono, a division of Merck KGaA, Darmstadt, …
f-star raises €15M in a New Financing led by SR One
To progress product candidates into development and maximise potential of the Modular Antibody Technology Platform Vienna, Austria, (13 April, 2011) -- f-star GmbH, a biopharmaceutical company …